Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy
In-vivo dosimetry (IVD) is a patient specific measure of quality control and safety during radiotherapy. With regard to current reporting thresholds for significant occurrences in radiotherapy defined by German regulatory authorities, the present study examines the clinical feasibility of superficia...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
30 October 2021
|
| In: |
Radiation oncology
Year: 2021, Jahrgang: 16, Pages: 1-13 |
| ISSN: | 1748-717X |
| DOI: | 10.1186/s13014-021-01938-8 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13014-021-01938-8 |
| Verfasserangaben: | Sebastian Höfel, Matteo Gandalini, Michael K. Fix, Malte Drescher and Felix Zwicker |
| Zusammenfassung: | In-vivo dosimetry (IVD) is a patient specific measure of quality control and safety during radiotherapy. With regard to current reporting thresholds for significant occurrences in radiotherapy defined by German regulatory authorities, the present study examines the clinical feasibility of superficial electron paramagnetic resonance (EPR) IVD of cumulative total doses applied to breast cancer patients treated with helical intensity-modulated radiotherapy (tomotherapy). |
|---|---|
| Beschreibung: | Gesehen am 04.02.2022 |
| Beschreibung: | Online Resource |
| ISSN: | 1748-717X |
| DOI: | 10.1186/s13014-021-01938-8 |